_
Dear Joe, thank you for your question. If your three main coronary arteries have no significant (stenosis > 50%) blockages, then your prognosis should be good. The smaller, branch vessels that were found to have significant stenoses are too small to be treated with angioplasty/stenting, but could still cause you to experience chest pain. Thus, medications are the way to go. Norvasc was probably started to improve blood flow to the areas of the heart muscle served by the blocked branch arteries. This should help to relieve your chest pain in turn. Collateral blood vessels from to "auto-bypass" blockages in coronary arteries. Since your blockages are in small arteries, collaterals are not as important. There is nothing in particular that you can do to increase the number of collaterals that you have, but you should practice a "heart-healthy" lifestyle including daily exercise, a low-fat diet, and avoidance of tobacco and alcohol. I don't know why you were placed on light exertion, so ask your cardiologist about that. EECP is not a proven treatment and involves wearing a cumbersome device over the pelvis and legs that vigorously contracts via a hydraulic pump system. Thus, it is uncomfortable and no studies have proven that EECP is an effective treatment. Therefore, I suggest that you save your money and stay away from EECP. If you following the previous advice and take your medications regularly as prescribed, you should have a good prognosis.
I hope you find this information useful. Information provided in the heart forum is for general purposes only. Only your physician can provide specific diagnoses and therapies. Please feel free to write back with additional questions. Good luck!
If you would like to make an appointment at the Cleveland Clinic Heart Center, please call 1-800-CCF-CARE or inquire online by using the Heart Center website at www.ccf.org/heartcenter. The Heart
Center website contains a directory of the cardiology staff that can be used to select the physician best suited to address your cardiac problem.